Skip to main content
Erschienen in: Brain Tumor Pathology 3/2017

23.06.2017 | Original Article

Pericytes promote abnormal tumor angiogenesis in a rat RG2 glioma model

verfasst von: Junji Hosono, Shunichi Morikawa, Taichi Ezaki, Takakazu Kawamata, Yoshikazu Okada

Erschienen in: Brain Tumor Pathology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

In glioma angiogenesis, tumor vessels cause morphological and functional abnormalities associated with malignancy and tumor progression. We hypothesized that certain structural changes or scantiness of functional pericytes may be involved in the formation of dysfunctional blood vessels in gliomas. In this study, we performed morphological examinations to elucidate the possible involvement of pericytes in brain tumor vessel abnormalities using a rat RG2 glioma model. After implantation of RG2 glioma cells in the syngeneic rat brain, gliomas were formed as early as day 7. In immunohistochemical examinations, desmin-positive pericytes, characterized by morphological abnormalities, were abundantly found on leaky vessels, as assessed by extravasation of lectin and high-molecular-weight dextrans. Interestingly, desmin-positive pericytes seemed to be characteristic of gliomas in rats. These pericytes were also found to express heat-shock protein 47, which plays an important role in the formation of the basement membrane, suggesting that RG2 pericytes promoted angiogenesis by producing basement membrane as a scaffold for newly forming blood vessels and caused functional abnormalities. We concluded that RG2 pericytes may be responsible for abnormal tumor angiogenesis lacking the functional ability to maintain the blood–brain barrier.
Literatur
2.
Zurück zum Zitat Wesseling P, Ruiter DJ, Burger PC (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 32:253–265CrossRefPubMed Wesseling P, Ruiter DJ, Burger PC (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 32:253–265CrossRefPubMed
3.
Zurück zum Zitat Plate KH, Breier G, Weich HA et al (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848CrossRefPubMed Plate KH, Breier G, Weich HA et al (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845–848CrossRefPubMed
4.
5.
6.
Zurück zum Zitat He T, Smith N, Saunders D et al (2013) Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models. Am J Nucl Med Mol Imaging 3:300–311PubMedPubMedCentral He T, Smith N, Saunders D et al (2013) Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models. Am J Nucl Med Mol Imaging 3:300–311PubMedPubMedCentral
7.
Zurück zum Zitat Barth RF, Kaur B (2009) Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299–312CrossRefPubMedPubMedCentral Barth RF, Kaur B (2009) Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 94:299–312CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Jain RK, di Tomaso E, Duda DG et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610–622CrossRefPubMed Jain RK, di Tomaso E, Duda DG et al (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610–622CrossRefPubMed
10.
Zurück zum Zitat Vallon M, Chang J, Zhang H et al (2014) Developmental and pathological angiogenesis in the central nervous system. Cell Mol Life Sci 71:3489–3506CrossRefPubMedPubMedCentral Vallon M, Chang J, Zhang H et al (2014) Developmental and pathological angiogenesis in the central nervous system. Cell Mol Life Sci 71:3489–3506CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Ribatti D, Nico B, Crivellato E (2011) The role of pericytes in angiogenesis. Int J Dev Biol 55:261–268CrossRefPubMed Ribatti D, Nico B, Crivellato E (2011) The role of pericytes in angiogenesis. Int J Dev Biol 55:261–268CrossRefPubMed
14.
15.
Zurück zum Zitat Sampetrean O, Saga I, Nakanishi M et al (2011) Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia 13:784–791CrossRefPubMedPubMedCentral Sampetrean O, Saga I, Nakanishi M et al (2011) Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia 13:784–791CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bulnes S, Bengoetxea H, Ortuzar N et al (2012) Angiogenic signalling pathways altered in gliomas: selection mechanisms for more aggressive neoplastic subpopulations with invasive phenotype. J Signal Transduct 2012:597915PubMedPubMedCentral Bulnes S, Bengoetxea H, Ortuzar N et al (2012) Angiogenic signalling pathways altered in gliomas: selection mechanisms for more aggressive neoplastic subpopulations with invasive phenotype. J Signal Transduct 2012:597915PubMedPubMedCentral
17.
Zurück zum Zitat Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000CrossRefPubMedPubMedCentral Morikawa S, Baluk P, Kaidoh T et al (2002) Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160:985–1000CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hoffmann A, Bredno J, Wendland M et al (2011) High and low molecular weight fluorescein isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl Stroke Res 2:106–111CrossRefPubMed Hoffmann A, Bredno J, Wendland M et al (2011) High and low molecular weight fluorescein isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl Stroke Res 2:106–111CrossRefPubMed
19.
Zurück zum Zitat Matsui A, Yokoo H, Negishi Y et al (2012) CXCL17 expression by tumor cells recruits CD11b + Gr1 high F4/80-cells and promotes tumor progression. PLoS ONE 7:e44080CrossRefPubMedPubMedCentral Matsui A, Yokoo H, Negishi Y et al (2012) CXCL17 expression by tumor cells recruits CD11b + Gr1 high F4/80-cells and promotes tumor progression. PLoS ONE 7:e44080CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Sudou N, Garces-Vasconez A, Lopez-Latorre MA et al (2016) Transcription factors Mix1 and VegT, relocalization of vegt mRNA, and conserved endoderm and dorsal specification in frogs. Proc Natl Acad Sci USA 113:5628–5633CrossRefPubMedPubMedCentral Sudou N, Garces-Vasconez A, Lopez-Latorre MA et al (2016) Transcription factors Mix1 and VegT, relocalization of vegt mRNA, and conserved endoderm and dorsal specification in frogs. Proc Natl Acad Sci USA 113:5628–5633CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Charalambous C, Chen TC, Hofman FM (2006) Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus 20:E22CrossRefPubMed Charalambous C, Chen TC, Hofman FM (2006) Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus 20:E22CrossRefPubMed
22.
Zurück zum Zitat Hall AP (2006) Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34:763–775CrossRefPubMed Hall AP (2006) Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34:763–775CrossRefPubMed
23.
Zurück zum Zitat Nehls V, Denzer K, Drenckhahn D (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469–474CrossRefPubMed Nehls V, Denzer K, Drenckhahn D (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469–474CrossRefPubMed
25.
Zurück zum Zitat Baluk P, Morikawa S, Haskell A et al (2003) Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163:1801–1815CrossRefPubMedPubMedCentral Baluk P, Morikawa S, Haskell A et al (2003) Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 163:1801–1815CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Morikawa S, Ezaki T (2011) Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol Histopathol 26:979–995PubMed Morikawa S, Ezaki T (2011) Phenotypic changes and possible angiogenic roles of pericytes during wound healing in the mouse skin. Histol Histopathol 26:979–995PubMed
27.
Zurück zum Zitat Mustafa DA, Burgers PC, Dekker LJ et al (2007) Identification of glioma neovascularization-related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels. Mol Cell Proteomics 6:1147–1157CrossRefPubMed Mustafa DA, Burgers PC, Dekker LJ et al (2007) Identification of glioma neovascularization-related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels. Mol Cell Proteomics 6:1147–1157CrossRefPubMed
28.
Zurück zum Zitat Wu ZB, Cai L, Lin SJ et al (2015) Heat shock protein 47 promotes glioma angiogenesis. Brain Pathol 26(1):31–42CrossRefPubMed Wu ZB, Cai L, Lin SJ et al (2015) Heat shock protein 47 promotes glioma angiogenesis. Brain Pathol 26(1):31–42CrossRefPubMed
29.
Zurück zum Zitat Matsuoka Y, Kubota H, Adachi E et al (2004) Insufficient folding of type IV collagen and formation of abnormal basement membrane-like structure in embryoid bodies derived from Hsp47-null embryonic stem cells. Mol Biol Cell 15:4467–4475CrossRefPubMedPubMedCentral Matsuoka Y, Kubota H, Adachi E et al (2004) Insufficient folding of type IV collagen and formation of abnormal basement membrane-like structure in embryoid bodies derived from Hsp47-null embryonic stem cells. Mol Biol Cell 15:4467–4475CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Jeon H, Ono M, Kumagai C et al (1996) Pericytes from microvessel fragment produce type IV collagen and multiple laminin isoforms. Biosci Biotechnol Biochem 60:856–861CrossRefPubMed Jeon H, Ono M, Kumagai C et al (1996) Pericytes from microvessel fragment produce type IV collagen and multiple laminin isoforms. Biosci Biotechnol Biochem 60:856–861CrossRefPubMed
31.
Zurück zum Zitat Inai T, Mancuso M, Hashizume H et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35–52CrossRefPubMedPubMedCentral Inai T, Mancuso M, Hashizume H et al (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35–52CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Mitsuhashi J, Morikawa S, Shimizu K et al (2013) Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Exp Eye Res 106:64–73CrossRefPubMed Mitsuhashi J, Morikawa S, Shimizu K et al (2013) Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Exp Eye Res 106:64–73CrossRefPubMed
33.
Zurück zum Zitat Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362CrossRefPubMed Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362CrossRefPubMed
35.
Zurück zum Zitat Sa-Pereira I, Brites D, Brito MA (2012) Neurovascular unit: a focus on pericytes. Mol Neurobiol 45:327–347CrossRefPubMed Sa-Pereira I, Brites D, Brito MA (2012) Neurovascular unit: a focus on pericytes. Mol Neurobiol 45:327–347CrossRefPubMed
36.
Zurück zum Zitat Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215CrossRefPubMed Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21:193–215CrossRefPubMed
37.
Zurück zum Zitat Betsholtz C (2004) Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15:215–228CrossRefPubMed Betsholtz C (2004) Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15:215–228CrossRefPubMed
38.
Zurück zum Zitat Arentz G, Chataway T, Price TJ et al (2011) Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels. Clin Proteomics 8:16CrossRefPubMedPubMedCentral Arentz G, Chataway T, Price TJ et al (2011) Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels. Clin Proteomics 8:16CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15–23CrossRefPubMed Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15–23CrossRefPubMed
Metadaten
Titel
Pericytes promote abnormal tumor angiogenesis in a rat RG2 glioma model
verfasst von
Junji Hosono
Shunichi Morikawa
Taichi Ezaki
Takakazu Kawamata
Yoshikazu Okada
Publikationsdatum
23.06.2017
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 3/2017
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-017-0291-y

Weitere Artikel der Ausgabe 3/2017

Brain Tumor Pathology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.